Luis Miguel Gonzalez-Perez

Prof. Dr. Luis Miguel Gonzalez-Perez

Department of Surgery. University of Seville
orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Medicina Oral Patología Oral y Cirugia Bucal
Verified
Journal Article
Open access
Luis Miguel Gonzalez-PerezLuis Miguel Gonzalez-Perez
Luis Miguel Gonzalez-Perez
Pedro Infante-CossioPedro Infante-Cossio
Pedro Infante-Cossio
MGM. Granados-Nunez
M. Granados-Nunez
FUFj. Urresti-Lopez
Fj. Urresti-Lopez
RLR. Lopez-Martos
R. Lopez-Martos
PRP. Ruiz-Canela-Mendez
P. Ruiz-Canela-Mendez
To determine whether deep dry needling (DDN) of trigger points (TPs) in the lateral pterygoid muscle (LPM) would significantly reduce pain and improve function, compared with methocarbamol/paracetamol medication. Forty-eight patients with chronic myofascial pain located in the LPM were selected and randomly assigned to one of two groups (DDN test group, n=24; drug-treated control group, n=24). The test group received three applications of needling of the LPM once per week for three weeks, while control group patients were given two tablets of a methocarbamol/paracetamol combination every six hours for three weeks. Assessments were carried out pre-treatment, 2 and 8 weeks after finishing the treatment. A statistically significant difference (p<0.05) was detected for both groups with respect to pain reduction at rest and with mastication, but the DDN test group had significantly better levels of pain reduction. Moreover, statistically significant differences (p<0.05) up to day 70 in the test group were seen with respect to maximum mouth opening, laterality and protrusion movements compared with pre-treatment values. Pain reduction in the test group was greater as a function of pain intensity at baseline. The evaluation of efficacy as assessed both by patients/investigators was better for the test group. 41% of the patients receiving the combination drug treatment described unpleasant side effects (mostly drowsiness). DDN of TPs in the LPM showed better efficacy in reducing pain and improving maximum mouth opening, laterality, and protrusion movements compared with methocarbamol/paracetamol treatment. No adverse events were observed with respect to DDN.

23 December 2020 in Toxins
Verified
Journal Article
Open access
PDF file
JMJose Francisco Montes
Jose Francisco Montes
Luis Miguel Gonzalez-PerezLuis Miguel Gonzalez-Perez
Luis Miguel Gonzalez-Perez
Pedro Infante-CossioPedro Infante-Cossio
Pedro Infante-Cossio
Botulinum toxin type A (BTA) injection is considered an available alternative treatment for myofascial pain. However, its efficacy in treating masticatory myofascial pain syndrome (MMPS) remains unclear. The purpose of this study was to evaluate whether the BTA injection into the affected muscles would significantly reduce pain and improve function, and to assess its efficacy, safety, and therapeutic indications in a randomized, single-center clinical trial. Sixty patients with MMPS were randomized into three groups evenly to receive a single session injection of saline solution (SS group), lidocaine (LD group), and BTA (BTA group) in the masseter, temporal, and pterygoid muscles after an electromyographic study. Patients’ pain was classified as localized or referred according to the DC/TMD classification. Assessments were performed on pre-treatment, and subsequently, on days 7, 14, 28, 60, 90, and 180. A significant reduction in pain and improvement of mandibular movements was found in the BTA group compared to the SS and LD groups. The response lasted until day 180 and was more intense in patients with localized myalgia and focused myofascial pain than in referred remote pain. No significant adverse reactions were observed. A single BTA injection can be considered an effective treatment option in patients with localized MMPS by reducing pain and improving mandibular movements, which persisted up to 6 months.

31 December 2017 in Medicina Oral Patología Oral y Cirugia Bucal
Verified
Journal Article
Open access
RLR Lopez-Martos
R Lopez-Martos
Luis Miguel Gonzalez-PerezLuis Miguel Gonzalez-Perez
Luis Miguel Gonzalez-Perez
PRP Ruiz-Canela-Mendez
P Ruiz-Canela-Mendez
FUFj Urresti-Lopez
Fj Urresti-Lopez
JGJl Gutierrez-Perez
Jl Gutierrez-Perez
Pedro Infante-CossioPedro Infante-Cossio
Pedro Infante-Cossio
Background: To assess whether the techniques of percutaneous needle electrolysis (PNE) and deep dry needling (DDN) used on trigger points (TrP) of lateral pterygoid muscle (LPM) can significantly reduce pain and improve function in patients with myofascial pain syndrome (MPS) compared to a control group treated with a sham needling procedure (SNP). Material and Methods: Sixty patients diagnosed with MPS in the LPM were selected and randomly assigned to one of three groups. The PNE group received electrolysis to the LPM via transcutaneous puncture. The DDN group received a deep puncture to the TrP without the introduction of any substance. In the SNP group, pressure was applied to the skin without penetration. Procedures were performed once per week for 3 consecutive weeks. Clinical evaluation was performed before treatment, and on days 28, 42 and 70 after treatment. Results: Statistically significant differences (p < 0.01) were measured for the PNE and DDN groups with respect to pain reduction at rest, during chewing, and for maximum interincisal opening (MIO). Values for the PNE group showed significantly earlier improvement. Differences for PNE and DDN groups with respect to SNP group were significant (p < 0.05) up to day 70. Evaluation of efficacy as reported by the patient and observer was better for PNE and DDN groups. No adverse events were observed for either of the techniques. Conclusions: PNE and DDN of the LPM showed greater pain reduction efficacy and improved MIO compared to SNP. Improvement was noted earlier in the PNE group than in the DDN group.

1 January 2012 in Medicina Oral Patología Oral y Cirugia Bucal
Verified
Journal Article
Open access
Luis Miguel Gonzalez-PerezLuis Miguel Gonzalez-Perez
Luis Miguel Gonzalez-Perez
Pedro Infante-CossioPedro Infante-Cossio
Pedro Infante-Cossio
MGM. Granados-Nunez
M. Granados-Nunez
FUFj. Urresti-Lopez
Fj. Urresti-Lopez
Objectives: The present study was designed to evaluate the usefulness of deep dry needling in the treatment of temporomandibular myofascial pain. Study Design: We selected 36 patients with myofascial pain located in the external pterygoid muscle (30 women/6 men, mean age=27 years with SD±6,5). We studied differences in pain with a visual analog scale and range of mandibular movements before and after intervention. Results: We found a statistically significant relationship (p<0,01) between therapeutic intervention and the improvement of pain and jaw movements, which continued up to 6 months after treatment. Pain reduction was greater the higher was the intensity of pain at baseline. Conclusions: Although further studies are needed, our findings suggest that deep dry needling in the trigger point in the external pterygoid muscle can be effective in the management of patients with myofascial pain located in that muscle.

1 January 2016 in International Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
Luis Miguel Gonzalez-PerezLuis Miguel Gonzalez-Perez
Luis Miguel Gonzalez-Perez
NFN. Fakih-Gomez
N. Fakih-Gomez
BGB. Gonzalez-Perez-Somarriba
B. Gonzalez-Perez-Somarriba
Gabriel CentenoGabriel Centeno
Gabriel Centeno
JMJ.F. Montes-Carmona
J.F. Montes-Carmona

20 June 2017 in Rapid Prototyping Journal
Verified
Journal Article
Closed access
Gabriel CentenoGabriel Centeno
Gabriel Centeno
Domingo Morales-PalmaDomingo Morales-Palma
Domingo Morales-Palma
BGBorja Gonzalez-Perez-Somarriba
Borja Gonzalez-Perez-Somarriba
IBIsabel Bagudanch
Isabel Bagudanch
JEJUAN JOSE José EGEA-GUERRERO
JUAN JOSE José EGEA-GUERRERO
Carpóforo VallellanoCarpóforo Vallellano
Carpóforo Vallellano
This paper aims to propose a functional methodology to produce cranial prostheses in polymeric sheet. Within the scope of rapid prototyping technologies, the single-point incremental forming (SPIF) process is used to demonstrate its capabilities to perform customized medical parts. The methodology starts processing a patient’s computerized axial tomography (CAT) and follows with a computer-aided design and manufacture (CAD/CAM) procedure, which finally permits the successful manufacturing of a customized prosthesis for a specific cranial area. The formability of a series of polymeric sheets is determined and the most restrictive material among them is selected for the fabrication of a specific partial cranial prosthesis following the required geometry. The final strain state at the outer surface of the prosthesis is analysed, showing the high potential of SPIF in manufacturing individualized cranial prostheses from polymeric sheet. This paper proposes a complete methodology to design and manufacture polymer customized cranial prostheses from patients’ CATs using the novel SPIF technology. This is an application of a new class of materials to the manufacturing of medical prostheses by SPIF, which to this purpose has been mainly making use of metallic materials so far. Despite the use of polymers to this application is still to be validated from a medical point of view, transparent prostheses can already be of great interest in medical or engineering schools for teaching and research purposes.